HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Divine Skin in talks with Bayer

This article was originally published in The Rose Sheet

Executive Summary

Topical hair growth developer Divine Skin has entered into preliminary discussions with Bayer Vital GmbH relating to hair-care products, though a formal relationship has not yet formed, according to a May 26 release. Divine's brand portfolio includes three hair regrowth treatments, including Spectral.RS, an advanced minoxidil-free topical hair-regrowth treatment positioned as a natural alternative to minoxidil. Product contains no drug compounds and is formulated with extracts of ivy, hops and capsicum. Unique nanosomes act as carrier agents and enhance absorption of the product. According to firm's website, the compounds in Spectral.RS "specifically work to improve the nutrition, circulation and metabolism of the follicle." Divine Skin also offers a cellulite-reducing gel, body hair minimizer and double-chin reducer, along with anti-aging and acne products
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS016956

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel